Vivek Kamath holds a Ph.D. in Synthetic Organic Chemistry and has extensive experience in pharmaceutical development spanning 25 years. They have led cross-functional teams in developing drugs such as Peramivir for Influenza B and Forodesine for T-cell Leukemia, overseeing all stages from candidate nomination to commercial launch. Currently, Vivek serves as Sr. Director of Strategic Partnership CMC at Pharmaron, participating in multidisciplinary teams for oncology and other asset developments. Previously, they held leadership roles at Allergan and AbbVie, managing API candidates and ensuring compliance with regulatory guidelines.
Location
Birmingham, United States
This person is not in any offices